OTTAWA, Oct. 3, 2016 /CNW/ - Many Canadians are struggling with opioid misuse and need access to better treatment. When Canadians
Today, the Honourable Jane Philpott,
Naloxone can save lives when used promptly, by temporarily reversing a potentially fatal opioid overdose, and the nasal spray is considered to be easier to use than the injectable version, particularly by those who are not healthcare professionals.
With federal market authorization, the manufacturer is now able to take the necessary steps to bring the Canadian naloxone nasal spray to market. In the meantime, the Interim Order will remain in effect and the US-approved product will continue to be available in Canada, to avoid any interruption in supply.
"Canada is facing a growing number of opioid overdoses and deaths occurring across the country. This crisis demands that we take action now, and I'm proud to see my department working with its neighbours in the United States, and expediting approvals here in Canada, to provide Canadians with much-needed treatment options." Jane PhilpottMinister of Health
Health Canada Allowing Immediate Access to Nasal Naloxone announcement July 2016 Health Canada Statement on Change to Prescription Drug List for Naloxone Health Canada's Action on Opioid Misuse
Interim OrderIndustry Notice on Change to Prescription Drug List for Naloxone
Health Canada news releases are available on the Internet at: www.healthcanada.gc.ca/media
SOURCE Health Canada
Subscribe to our Free Newsletters!
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...
Hashimoto's thyroiditis is an autoimmune disorder of the thyroid causing hypothyroidism. Synthetic ...
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...View All